Lynx1 Capital Management LP Diversified Active

CIK: 0001910456 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value ($000): $346,173 (100.0% shares, 0.0% debt)

Holdings (15)

— MERUS N V 23.8%

Value ($000) $82,521 Shares 1,568,841 Est. Cost $36.34 Unrealized —

GHRS GH RESEARCH PLC 23.8%

Value ($000) $82,245 Shares 6,746,951 Est. Cost $9.63 Unrealized +13.8%

STOK STOKE THERAPEUTICS INC 17.7%

Value ($000) $61,343 Shares 5,404,674 Est. Cost $8.00 Unrealized +18.7%

PTGX PROTAGONIST THERAPEUTICS INC 11.7%

Value ($000) $40,514 Shares 733,014 Est. Cost $41.90 Unrealized +14.5%

CGEM CULLINAN THERAPEUTICS INC 9.6%

Value ($000) $33,138 Shares 4,400,842 Est. Cost $11.16 Unrealized -28.0%

ALLO ALLOGENE THERAPEUTICS INC 3.6%

Value ($000) $12,494 Shares 11,057,009 Est. Cost $2.63 Unrealized -49.4%

TCRX TSCAN THERAPEUTICS INC 3.3%

Value ($000) $11,393 Shares 7,857,347 Est. Cost $2.32 Unrealized -37.7%

CCCC C4 THERAPEUTICS INC 2.9%

Value ($000) $10,150 Shares 7,098,133 Est. Cost $4.48 Unrealized -67.5%

DTIL PRECISION BIOSCIENCES INC 1.3%

Value ($000) $4,351 Shares 1,036,051 Est. Cost $6.69 Unrealized -26.2%

— PASSAGE BIO INC 1.1%

Value ($000) $3,706 Shares 9,256,953 Est. Cost $1.03 Unrealized —

UPB UPSTREAM BIO INC 0.7%

Value ($000) $2,407 Shares 219,247 Est. Cost $22.33 Unrealized -58.6%

IBIO IBIO INC 0.3%

Value ($000) $1,174 Shares 1,538,573 Est. Cost $1.47 Unrealized -26.2%

NEUP NEUPHORIA THERAPEUTICS INC 0.1%

Value ($000) $325 Shares 45,806 Est. Cost $3.53 Unrealized +64.3%

DSGN DESIGN THERAPEUTICS INC 0.1%

Value ($000) $222 Shares 65,954 Est. Cost $4.77 Unrealized -21.6%

ASMB ASSEMBLY BIOSCIENCES INC 0.1%

Value ($000) $188 Shares 10,366 Est. Cost $13.19 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	1,568,841	$82,521	23.8%	$36.34	—	COM	N5749R100
GHRS	GH RESEARCH PLC	6,746,951	$82,245	23.8%	$9.63	+13.8%	ORDINARY SHARES	G3855L106
STOK	STOKE THERAPEUTICS INC	5,404,674	$61,343	17.7%	$8.00	+18.7%	COM	86150R107
PTGX	PROTAGONIST THERAPEUTICS INC	733,014	$40,514	11.7%	$41.90	+14.5%	COM	74366E102
CGEM	CULLINAN THERAPEUTICS INC	4,400,842	$33,138	9.6%	$11.16	-28.0%	COM	230031106
ALLO	ALLOGENE THERAPEUTICS INC	11,057,009	$12,494	3.6%	$2.63	-49.4%	COM	019770106
TCRX	TSCAN THERAPEUTICS INC	7,857,347	$11,393	3.3%	$2.32	-37.7%	COM	89854M101
CCCC	C4 THERAPEUTICS INC	7,098,133	$10,150	2.9%	$4.48	-67.5%	COM STK	12529R107
DTIL	PRECISION BIOSCIENCES INC	1,036,051	$4,351	1.3%	$6.69	-26.2%	COM NEW	74019P207
—	PASSAGE BIO INC	9,256,953	$3,706	1.1%	$1.03	—	COM	702712100
UPB	UPSTREAM BIO INC	219,247	$2,407	0.7%	$22.33	-58.6%	COM	91678A107
IBIO	IBIO INC	1,538,573	$1,174	0.3%	$1.47	-26.2%	COM NEW	451033708
NEUP	NEUPHORIA THERAPEUTICS INC	45,806	$325	0.1%	$3.53	+64.3%	COM	64136E102
DSGN	DESIGN THERAPEUTICS INC	65,954	$222	0.1%	$4.77	-21.6%	COM	25056L103
ASMB	ASSEMBLY BIOSCIENCES INC	10,366	$188	0.1%	$13.19	0.0%	COM NEW	045396207